Yelisudan Mulati
No. 107 Yanjiang West Road, Yuexiu District
Guangzhou, 510180, China
Guangzhou, 510180, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Corrigendum to "PSMA RNA aptamer A10-3.2 conjugated with indocyanine green for rapid intraoperative imaging and effective mild photothermal therapy of prostate cancer" [Int. J. Biol. Macromol. 2026 Feb; 341(Pt 2):150303].
Journal: International journal of biological macromolecules
Published: July 29, 2026
A serum-clinical composite model for prostate cancer diagnosis: multicenter validation and CRISPR/Cas13a-based detection.
Journal: The journal of liquid biopsy
Published: June 22, 2026
PSMA RNA aptamer A10-3.2 conjugated with indocyanine green for rapid intraoperative imaging and effective mild photothermal therapy of prostate cancer.
Journal: International journal of biological macromolecules
Published: August 27, 2025
Comprehensive analysis of m7G-related genes METTL1 and WDR4 for predicting prognosis and oncogenic functions in prostate cancer.
Journal: Discover oncology
Published: December 28, 2024
Integrative analysis regarding the correlation between collagen-related genes and prostate cancer.
Journal: BMC cancer
Published: April 25, 2024
The predictive significance of chromobox family members in prostate cancer in humans.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: February 20, 2024
Nomograms for Predicting Postoperative Sperm Improvements in Varicocele Patients.
Journal: European urology open science
Published: November 18, 2023
Single-cell analysis extracted CAFs-related genes to established online app to predict clinical outcome and radiotherapy prognosis of prostate cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 14, 2023
Establishment of a prognostic risk prediction model incorporating disulfidptosis-related lncRNA for patients with prostate cancer.
Journal: BMC cancer
Published: September 11, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026